AIRSNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Airsculpt Technologies, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$1.25−0.03 (-2.35%)
Close on Oct 19, 2026
- Market cap
- $88.13M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2018 to 2025
Gross margin
59.4%−3.2 pts over 5 years
Operating margin
-7.6%−23.6 pts over 5 years
Net margin
-7.7%−19.8 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -15.8% | -3.5% | +19.3% | – | |
| Gross profit | -17.5% | -5.3% | +18.1% | – | |
| Free cash flow | – | -60.8% | -41.7% | – |
Returns and balance sheet
8 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2018 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | – | -14.1% | |
| Return on assets | – | – | -5.8% | |
| Current ratio | – | 1.22 | 0.55 | |
| Debt to equity | – | – | 0.64 | |
| Net debt to EBITDA | – | 1.41× | 38.98× | |
| Interest coverage | – | 4.1× | -1.9× | |
| Capex to revenue | – | 5.9% | 1.6% | |
| Diluted shares | – | – | 60M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Airsculpt Technologies generated $89.48M from operations and spent $70.16M on capital expenditure, dividends and share buybacks. 66% of that went back into the business.
Generated
$89.48M
Used
$70.16M
Capital expenditure$46.37M66%Dividends$23.80M34%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-7.7%
×Asset turnover0.76×
×Equity multiplier2.41×
=Return on equity, FY2025-14.1%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -7.7% | 0.76× | 2.41× | -14.1% |
| FY2024 | -4.4% | 0.87× | 2.59× | -10.0% |
| FY2023 | -2.2% | 0.97× | 2.64× | -5.5% |
| FY2022 | -8.7% | 0.84× | 2.60× | -19.0% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
3of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero-$11.67M
- Cash generatingOperating cash flow above zero$3.10M
- Return on assets improvedROA up on the prior year-3.9% → -5.5%
- Earnings backed by cashOperating cash flow above net income$3.10M vs -$11.67M
- Less leverageLong-term debt to assets fell30.8% → 27.0%
- Better liquidityCurrent ratio rose0.59 → 0.55
- No dilutionShare count did not rise58M → 60M
- Gross margin improvedGross margin up on the prior year60.55% → 59.37%
- More efficientAsset turnover rose0.88 → 0.71